Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Concert Pharmaceuticals Inc announces closing of initial public offering


Wednesday, 19 Feb 2014 11:30am EST 

Concert Pharmaceuticals Inc:Closes of its initial public offering of 6,000,000 shares of its common stock at a public offering price of $14.00 per share, before underwriting discounts.UBS Investment Bank and Wells Fargo Securities joint book-running managers.JMP Securities lead manager and Roth Capital Partners co-manager. 

Company Quote

8.86
-0.05 -0.56%
3:59pm EDT